Methodology for systematic analysis of in vivo efficacy material base of traditional Chinese medicine--Chinmedomics.
- Author:
Wang XI-JUN
- Publication Type:Journal Article
- MeSH:
Animals;
Biomarkers;
blood;
Drug Evaluation;
methods;
standards;
Drugs, Chinese Herbal;
pharmacokinetics;
Humans;
Metabolomics;
Phytotherapy
- From:
China Journal of Chinese Materia Medica
2015;40(1):13-17
- CountryChina
- Language:Chinese
-
Abstract:
The efficacy material base of traditional Chinese medicines (TCMs) is those constituents absorbed in blood and show the efficacy of TCMs after oral administration of a TCM formula. In TCM, formula consisted of more than one herbal drug is the clinical medication form which corresponding to TCM syndrome. The efficacy material base of TCMs had to be found in the condition of compatibility and efficacy of TCM formula. Therefore we take the biological characters of TCM syndrome as a research starting point, taking formula as object, through the integration of serum pharmacochemistry of TCM methods and metabolomics technologies, establish a system research methodology of the efficacy material basis in vivo--Chinmedomics. The use of metabolomics technology is used to fully understand nature biology on syndromes or disease, identify biomarkers for disease to bridging disease animal model, establishing the biological evaluation system of traditional Chinese medicine. On the basis of the validity of the premise, the use of serum pharmacochemistry of TCM to analysis in vivo directly substance after oral prescription and dynamic law, combined with changes law of the endogenous disease biomarkers (pharmacodynamic markers of TCM), Though establishing two variable correlation analysis method between Chinese chemical compositions in serum exogenous and endogenous biomarkers, to extract TCM compositions highly correlated with the endogenous marker as potential basis for traditional Chinese medicines, and to biological validation to determine the efficacy material basis of TCM.
